Browsing: Drug development

Brexit BZ

Brexit or no Brexit? The question that has been weighing on the UK for the past 3 years will soon have an answer (hopefully). Read this commentary from Zamas Lam (QPS; DE, USA) discussing how Brexit relates to the future of drug discovery, preclinical and clinical drug development.

BOSCA winner 2019

Bioanalysis Zone is proud to announce the 2019 Bioanalysis Outstanding Contribution Award winner – find out who has won this year’s award here!

1 2 3 6